Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Teva
Cipla
Johnson and Johnson
Chinese Patent Office
Daiichi Sankyo
Merck
Farmers Insurance
Federal Trade Commission
Boehringer Ingelheim

Generated: October 23, 2017

DrugPatentWatch Database Preview

Hikma Intl Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for HIKMA INTL PHARMS, and when can generic versions of HIKMA INTL PHARMS drugs launch?

HIKMA INTL PHARMS has forty-two approved drugs.

There are four US patents protecting HIKMA INTL PHARMS drugs.

Summary for Applicant: Hikma Intl Pharms

US Patents:4
Tradenames:29
Ingredients:29
NDAs:42
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Intl Pharms
LISINOPRIL
lisinopril
TABLET;ORAL076063-002Jul 1, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
Hikma Intl Pharms
CHLOROTHIAZIDE
chlorothiazide
TABLET;ORAL086028-001Jul 14, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Hikma Intl Pharms
GLYCOPYRROLATE
glycopyrrolate
TABLET;ORAL040836-002Mar 5, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe
Hikma Intl Pharms
CAPTOPRIL
captopril
TABLET;ORAL074505-003Feb 13, 1996ABRXNoNo► Subscribe► Subscribe► Subscribe
Hikma Intl Pharms
DOXYCYCLINE HYCLATE
doxycycline hyclate
CAPSULE;ORAL065103-001May 13, 2005RXNoYes► Subscribe► Subscribe► Subscribe
Hikma Intl Pharms
LISINOPRIL
lisinopril
TABLET;ORAL076063-003Jul 1, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
Hikma Intl Pharms
RESERPINE
reserpine
TABLET;ORAL080975-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Hikma Intl Pharms
METHOCARBAMOL
methocarbamol
TABLET;ORAL085159-001Approved Prior to Jan 1, 1982AARXNoNo► Subscribe► Subscribe► Subscribe
Hikma Intl Pharms
HYDROCORTISONE
hydrocortisone
TABLET;ORAL083365-002Feb 23, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Hikma Intl Pharms
ISONIAZID
isoniazid
TABLET;ORAL087425-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Novartis
Harvard Business School
Colorcon
Express Scripts
Johnson and Johnson
Baxter
UBS
Queensland Health
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot